GB9711683D0 - Composition - Google Patents

Composition

Info

Publication number
GB9711683D0
GB9711683D0 GBGB9711683.4A GB9711683A GB9711683D0 GB 9711683 D0 GB9711683 D0 GB 9711683D0 GB 9711683 A GB9711683 A GB 9711683A GB 9711683 D0 GB9711683 D0 GB 9711683D0
Authority
GB
United Kingdom
Prior art keywords
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GBGB9711683.4A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Ltd
Original Assignee
SmithKline Beecham Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Beecham Ltd filed Critical SmithKline Beecham Ltd
Priority to GBGB9711683.4A priority Critical patent/GB9711683D0/en
Priority claimed from GBGB9712851.6A external-priority patent/GB9712851D0/en
Publication of GB9711683D0 publication Critical patent/GB9711683D0/en
Priority to BR9810405-5A priority patent/BR9810405A/pt
Priority to IL13307498A priority patent/IL133074A0/xx
Priority to NZ510672A priority patent/NZ510672A/xx
Priority to EA199901116A priority patent/EA002384B1/ru
Priority to CA002292629A priority patent/CA2292629C/en
Priority to SK1648-99A priority patent/SK164899A3/sk
Priority to APAP/P/1999/001696A priority patent/AP1214A/en
Priority to IL16014498A priority patent/IL160144A0/xx
Priority to CN98805686A priority patent/CN1112926C/zh
Priority to TR2000/02790T priority patent/TR200002790T2/xx
Priority to MXPA99011322A priority patent/MXPA99011322A/es
Priority to JP50158799A priority patent/JP2001521553A/ja
Priority to KR19997011411A priority patent/KR20010013410A/ko
Priority to CNA2003101199090A priority patent/CN1526391A/zh
Priority to TR1999/02963T priority patent/TR199902963T2/xx
Priority to PCT/EP1998/003478 priority patent/WO1998055122A1/en
Priority to HU0004070A priority patent/HUP0004070A3/hu
Priority to IDW991520A priority patent/ID24264A/id
Priority to AU82150/98A priority patent/AU8215098A/en
Priority to PL98337201A priority patent/PL337201A1/xx
Priority to CA002333352A priority patent/CA2333352A1/en
Priority to NZ523725A priority patent/NZ523725A/en
Priority to EP98932144A priority patent/EP0998284A1/en
Priority to DZ980120A priority patent/DZ2510A1/xx
Priority to ARP980102649A priority patent/AR008198A1/es
Priority to UY25032A priority patent/UY25032A1/es
Priority to CO98031614A priority patent/CO4940400A1/es
Priority to ARP980102650A priority patent/AR015120A1/es
Priority to ZA9804826A priority patent/ZA984826B/xx
Priority to ZA9811572A priority patent/ZA9811572B/xx
Priority to PE1998000466A priority patent/PE78899A1/es
Priority to TW087117536A priority patent/TW570797B/zh
Priority to OA9900267A priority patent/OA11306A/en
Priority to NO995938A priority patent/NO995938L/no
Priority to BG104048A priority patent/BG104048A/bg
Priority to NZ513922A priority patent/NZ513922A/xx
Priority to US10/068,514 priority patent/US20020177612A1/en
Priority to CN02149972A priority patent/CN1430959A/zh
Priority to US10/394,858 priority patent/US20030187030A1/en
Priority to US10/716,923 priority patent/US20040082621A1/en
Priority to NO20040738A priority patent/NO20040738L/no
Priority to US10/808,014 priority patent/US20040180937A1/en
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Diabetes (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicinal Preparation (AREA)
GBGB9711683.4A 1997-06-05 1997-06-05 Composition Pending GB9711683D0 (en)

Priority Applications (43)

Application Number Priority Date Filing Date Title
GBGB9711683.4A GB9711683D0 (en) 1997-06-05 1997-06-05 Composition
CA002333352A CA2333352A1 (en) 1997-06-05 1998-06-02 Composition comprising 5-¬4-¬2-(n-methyl-n-2-pyridyl)amino)ethoxy|benzyl|thiazolidine-2,4-dione
PCT/EP1998/003478 WO1998055122A1 (en) 1997-06-05 1998-06-02 Composition comprising 5-[4-[2-(n-methyl-n-2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2,4-dione
AU82150/98A AU8215098A (en) 1997-06-05 1998-06-02 Composition comprising 5-(4-(2-(N-methyl-N-2-pyridyl)amino) ethoxy)benzyl)thiazolidine-2,4-dione
NZ523725A NZ523725A (en) 1997-06-05 1998-06-02 Composition comprising 5-[4-[2-(N-methyl-N-2-pyridyl)-amino)-ethoxy]benzyl]thiazolidine-2-4-dione
NZ510672A NZ510672A (en) 1997-06-05 1998-06-02 Composition comprising 5-[4-[2-(N-Methyl-N-2-Pyridyl)Amino)-Ethoxy]Benzyl]Thiazolidine-2,4-Dione
IL13307498A IL133074A0 (en) 1997-06-05 1998-06-02 Composition comprising 5-[4-[2-(n-methyl-n-2-pyridyl) amino) ethoxy] benzyl] thiazolidine-2,4-dione
CA002292629A CA2292629C (en) 1997-06-05 1998-06-02 Composition comprising 5-[4-[2-(n-methyl-n-2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2,4-dione
SK1648-99A SK164899A3 (en) 1997-06-05 1998-06-02 Pharmaceutical composition, process for its production, and a composition
APAP/P/1999/001696A AP1214A (en) 1997-06-05 1998-06-02 Composition comprising 5-[4-[2-(n-methyl-n-2-pyridyl)amino) ethoxy} benzyl} thiazolidine-2, 4-dione.
IL16014498A IL160144A0 (en) 1997-06-05 1998-06-02 Composition comprising 5-[4-[2-(n-methyl-n-2-pyridyl) amino) ethoxy] benzyl] thiazolidine-2, 4-dione
CN98805686A CN1112926C (zh) 1997-06-05 1998-06-02 含有5－[4－[2－(n－甲基－n－2－吡啶基)氨基)乙氧基]苄基]噻唑烷－2,4－二酮的组合物
TR2000/02790T TR200002790T2 (tr) 1997-06-05 1998-06-02 5-(4-(2-(N-metil-N-2-piridil) amino)etoksi) benzil)tiazolidin-2,4-dion içeren terkip
MXPA99011322A MXPA99011322A (es) 1997-06-05 1998-06-02 Composicion que comprende [5-[4 -[2-(n- metil-n-2piridil) amino)etoxi] bencil] tiazolidino-2, 4-diona.
JP50158799A JP2001521553A (ja) 1997-06-05 1998-06-02 ５−［４−［２−（ｎ−メチル−ｎ−２−ピリジル）アミノ）エトキシ］ベンジル］チアゾリジン−２，４−ジオンを含む組成物
KR19997011411A KR20010013410A (ko) 1997-06-05 1998-06-02 5-[4-[2-(ｎ-메틸-ｎ-(2-피리딜)아미노)에톡시]벤질]티아졸리딘-2,4-디온을 함유하는 조성물
CNA2003101199090A CN1526391A (zh) 1997-06-05 1998-06-02 含有5-［4-［2-(n-甲基-n-2-吡啶基)氨基)乙氧基］苄基］噻唑烷-2，4-二酮的组合物
TR1999/02963T TR199902963T2 (xx) 1997-06-05 1998-06-02 5-$4-$2-(N-Metil-N-2-Piridil)Amino) Etoksi]Benzil]Tiazolidin-2,4-Dion i�eren terkip
EP98932144A EP0998284A1 (en) 1997-06-05 1998-06-02 Composition comprising 5-[4-[2-(n-methyl-n-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2,4-dione
HU0004070A HUP0004070A3 (en) 1997-06-05 1998-06-02 Composition comprising 5-[4-[2-(n-methyl-n-2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2,4-dione
IDW991520A ID24264A (id) 1997-06-05 1998-06-02 Komposisi yang terdiri dari 5-[4-[2-(n-metil-n-2-piridil)amino) etoksi[benzil] tiazolidin-2,4-dion
BR9810405-5A BR9810405A (pt) 1997-06-05 1998-06-02 Composição que compreende 5-[4-[2-(n-metil-n-2-piridil) amino) etoxi] benzil] tiazolidino-2,4-diona
PL98337201A PL337201A1 (en) 1997-06-05 1998-06-02 Composition containing 5-[4-[2- ( n-methyl-n-2-pyridyl) amino ethoxy] benzyl] triazinolydino-2,4-dione
EA199901116A EA002384B1 (ru) 1997-06-05 1998-06-02 Композиция, включающая 5-[4-[2-(n-метил-n-(2-пиридил)амино)этокси]бензил]тиазолидин-2,4-дион
DZ980120A DZ2510A1 (fr) 1997-06-05 1998-06-03 Composition comprenant de la 5-Ä4-Ä2-(n-méthyl-n-(2-pyridyl)amino)éthoxyÜbenzylÜthiazolidine-2,4-dione et procédé pour sa préparation.
UY25032A UY25032A1 (es) 1997-06-05 1998-06-04 Procedimiento para preparar una nueva composicion
ZA9804826A ZA984826B (en) 1997-06-05 1998-06-04 Novel anti-diabetic composition.
ARP980102649A AR008198A1 (es) 1997-06-05 1998-06-04 Procedimiento para preparar una composicion farmaceutica de 5-[4-[2-(n- metil-n-(2-piridil)amino)etoxi]bencil]tiazolin-2,4-diona
CO98031614A CO4940400A1 (es) 1997-06-05 1998-06-04 Composiciones farmaceuticas
ZA9811572A ZA9811572B (en) 1997-06-05 1998-06-04 Novel anti-diabetic composition.
ARP980102650A AR015120A1 (es) 1997-06-05 1998-06-04 Composicion farmaceutica que comprende 5-[4-[2-(n-metil-n-(2-piridil)amino) etoxi]bencil]-tiazolidin-2,4-diona, un procedimiento para su preparacion, y unacomposicion para la pre-administracion farmaceutica
PE1998000466A PE78899A1 (es) 1997-06-05 1998-06-05 Composicion de 5-[4-[2-(n-metil-n-(2-piridil)amino)etoxi]bencil]tiazolidin-2,4-diona
TW087117536A TW570797B (en) 1997-06-05 1998-10-23 Pharmaceutical composition for the treatment of diabetes mellitus and conditions associated with diabetes mellitus
OA9900267A OA11306A (en) 1997-06-05 1999-12-02 Composition comprising 5-Ä4-Ä2-(n-2-pyridyl) amino) ethoxyÜbenzylÜbenzylÜthiazolidine-2, 4-dione
NO995938A NO995938L (no) 1997-06-05 1999-12-03 Blanding omfattende 5-[4-[2-(N-metyl-N-2- pyridyl)amino)etoksy]benzyl]tiazolidin-2,4-dion
BG104048A BG104048A (bg) 1997-06-05 1999-12-27 Състав съдържащ 5-/4-/2-(n-метил-n-2-пиридил) амино)- етокси/ бензин/ тиазолидин-2,4-дион
NZ513922A NZ513922A (en) 1997-06-05 2001-09-03 Composition comprising 5-Ä4-Ä2-(N-methyl-N-2-pyridyl)-amino)ethoxy!benzyl!thiazolidine-2-4-dione
US10/068,514 US20020177612A1 (en) 1997-06-05 2002-02-05 Composition comprising 5-[4-[2-(N-methyl-N-2-pyridy)amino)ethoxy]benzyl]thiazolidine-2,4-dione
CN02149972A CN1430959A (zh) 1997-06-05 2002-11-05 含有5－[4－[2－（n－甲基－n－2－吡啶基）氨基）乙氧基]苄基]噻唑烷－2，4－二酮的组合物
US10/394,858 US20030187030A1 (en) 1997-06-05 2003-03-21 Composition comprising 5-[4-[2-(N-methyl-N-2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2,4-dione
US10/716,923 US20040082621A1 (en) 1997-06-05 2003-11-19 Composition comprising 5-[4-[2-(N-methyl-N-2-pyridyl)amino)ethoxy]benzyl] thiazolidine-2,4-dione
NO20040738A NO20040738L (no) 1997-06-05 2004-02-20 Blanding omfattende 5- [4- [2- (N-metyl-N-2-pyridyl])-amino) etoksyl] bensyl] tiazolidin-2,4-dion.
US10/808,014 US20040180937A1 (en) 1997-06-05 2004-03-24 Composition comprising 5-[4-[2-(N-methyl-N-2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2,4-dione

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9711683.4A GB9711683D0 (en) 1997-06-05 1997-06-05 Composition
GBGB9712851.6A GB9712851D0 (en) 1997-06-18 1997-06-18 Composition
PCT/EP1998/003478 WO1998055122A1 (en) 1997-06-05 1998-06-02 Composition comprising 5-[4-[2-(n-methyl-n-2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2,4-dione

Publications (1)

Publication Number Publication Date
GB9711683D0 true GB9711683D0 (en) 1997-08-06

Family

ID=26311662

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB9711683.4A Pending GB9711683D0 (en) 1997-06-05 1997-06-05 Composition

Country Status (29)

Country Link
EP (1) EP0998284A1 (ja)
JP (1) JP2001521553A (ja)
KR (1) KR20010013410A (ja)
CN (3) CN1112926C (ja)
AP (1) AP1214A (ja)
AR (2) AR008198A1 (ja)
AU (1) AU8215098A (ja)
BG (1) BG104048A (ja)
BR (1) BR9810405A (ja)
CA (2) CA2333352A1 (ja)
CO (1) CO4940400A1 (ja)
DZ (1) DZ2510A1 (ja)
EA (1) EA002384B1 (ja)
GB (1) GB9711683D0 (ja)
HU (1) HUP0004070A3 (ja)
ID (1) ID24264A (ja)
IL (1) IL133074A0 (ja)
MX (1) MXPA99011322A (ja)
NO (2) NO995938L (ja)
NZ (2) NZ523725A (ja)
OA (1) OA11306A (ja)
PE (1) PE78899A1 (ja)
PL (1) PL337201A1 (ja)
SK (1) SK164899A3 (ja)
TR (2) TR199902963T2 (ja)
TW (1) TW570797B (ja)
UY (1) UY25032A1 (ja)
WO (1) WO1998055122A1 (ja)
ZA (2) ZA9811572B (ja)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TR200103061T2 (tr) 1999-04-23 2002-05-21 Smithkline Beecham P.L.C. Yeni farmasötik madde.
US20040248945A1 (en) 1999-04-23 2004-12-09 Smithkline Beecham P.L.C. Thiazolidinedione derivative and its use as antidiabetic
EP1173435B1 (en) * 1999-04-23 2003-07-30 SmithKline Beecham plc Polymorph of 5-[4-[2-(n-methyl-n-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2,4-dione maleic acid salt
GB0021978D0 (en) 2000-09-07 2000-10-25 Smithkline Beecham Plc Novel pharmaceutical
GB0127805D0 (en) * 2001-11-20 2002-01-09 Smithkline Beecham Plc Pharmaceutical composition
WO2003050112A1 (en) * 2001-12-13 2003-06-19 Smithkline Beecham Plc Toluenesulfonate hydrates of a thiazolidinedione derivative
GB0129876D0 (en) * 2001-12-13 2002-02-06 Smithkline Beecham Plc Novel pharmaceutical
GB0129871D0 (en) * 2001-12-13 2002-02-06 Smithkline Beecham Plc Novel pharmaceutical
GB0130509D0 (en) * 2001-12-20 2002-02-06 Smithkline Beecham Plc Novel pharmaceutical
EP2270007A1 (en) * 2006-05-09 2011-01-05 Teva Pharmaceutical Industries Ltd. 2-N-{5-[[4-[2-(methyl-2-pyridinylamino) ethoxy] phenyl]methyl]-2-4-thiazolidinedione} butanedioic acid, methods of preparation and compositions with rosiglitazone maleate
US7435741B2 (en) 2006-05-09 2008-10-14 Teva Pharmaceutical Industries, Ltd. 2-N{5-[[4-[2-(methyl-2-pyridinylamino) ethoxy] phenyl]methyl]-2,4-thiazolidinedione} butanedioic acid, methods of preparation and compositions with rosiglitazone maleate
WO2015008234A1 (en) * 2013-07-17 2015-01-22 Glenmark Pharmaceuticals S.A. Bicyclic heterocyclic compounds as ror gamma modulators

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE186724T1 (de) * 1987-09-04 1999-12-15 Beecham Group Plc Substituierte thiazolidindionderivate
GB9218830D0 (en) * 1992-09-05 1992-10-21 Smithkline Beecham Plc Novel compounds
WO1995021608A1 (en) * 1994-02-10 1995-08-17 Smithkline Beecham Plc Use of insulin sensitisers for treating renal diseases
SK16498A3 (en) * 1995-08-10 1999-03-12 Warner Lambert Co A method of reducing the amount of exogenous insulin administered to a patient having noninsulin-dependent diabetes mellitus
WO1997018811A1 (en) * 1995-11-17 1997-05-29 Warner-Lambert Company A method of treating myotonic dystrophy
NZ314406A (en) * 1996-03-18 2000-12-22 Sankyo Co Treatment or prophylaxis of pancreatitis with a medicament containing an insulin sensitiser including oxazoles and thiazoles
WO1998002159A1 (en) * 1996-07-12 1998-01-22 Smithkline Beecham Plc Novel treatment of leptine resistance

Also Published As

Publication number Publication date
AR015120A1 (es) 2001-04-18
AR008198A1 (es) 1999-12-29
EP0998284A1 (en) 2000-05-10
CA2292629C (en) 2004-01-06
UY25032A1 (es) 1998-11-26
BG104048A (bg) 2000-07-31
PL337201A1 (en) 2000-08-14
AU8215098A (en) 1998-12-21
NO20040738L (no) 2000-02-02
TW570797B (en) 2004-01-11
AP9901696A0 (en) 1999-12-31
EA199901116A1 (ru) 2000-06-26
CN1526391A (zh) 2004-09-08
BR9810405A (pt) 2000-08-29
ZA9811572B (en) 1999-07-22
OA11306A (en) 2003-10-22
HUP0004070A2 (hu) 2002-02-28
CN1430959A (zh) 2003-07-23
TR200002790T2 (tr) 2001-11-21
NZ523725A (en) 2004-09-24
TR199902963T2 (xx) 2000-02-21
NZ513922A (en) 2001-09-28
CN1259050A (zh) 2000-07-05
CA2333352A1 (en) 1998-12-10
DZ2510A1 (fr) 2003-01-25
NO995938L (no) 2000-02-02
NO995938D0 (no) 1999-12-03
CN1112926C (zh) 2003-07-02
WO1998055122A1 (en) 1998-12-10
KR20010013410A (ko) 2001-02-26
ZA984826B (en) 1999-08-03
SK164899A3 (en) 2000-11-07
CA2292629A1 (en) 1998-12-10
MXPA99011322A (es) 2004-12-02
JP2001521553A (ja) 2001-11-06
HUP0004070A3 (en) 2002-03-28
ID24264A (id) 2000-07-13
IL133074A0 (en) 2001-03-19
PE78899A1 (es) 1999-10-22
AP1214A (en) 2003-10-08
EA002384B1 (ru) 2002-04-25
CO4940400A1 (es) 2000-07-24

Similar Documents

Publication Publication Date Title
GB9704524D0 (en) Composition
GB9702238D0 (en) Compositions
GB9715203D0 (en) Composition
GB9713620D0 (en) Composition
GB9711683D0 (en) Composition
GB9714010D0 (en) Composition
GB9715489D0 (en) Composition
GB9726777D0 (en) Composition
EP0958806A4 (en) HAIR COLORING COMPOSITION
PL338017A1 (en) Novel composition
GB9726284D0 (en) Composition
GB9701031D0 (en) Composition
GB9714359D0 (en) Composition
GB9826467D0 (en) Composition
GB9724975D0 (en) Composition
GB9703109D0 (en) Compositions
GB9705110D0 (en) Composition
EG23068A (en) Pesticidale composition
GB9704525D0 (en) Composition
GB9722705D0 (en) Composition
GB9716806D0 (en) Composition
GB9716807D0 (en) Composition
GB9717392D0 (en) Composition
GB9712851D0 (en) Composition
GB9708197D0 (en) Composition